Psyence Biomedical (Psyence Biomedical) Interest Expense : $ Mil (TTM As of Mar. 2023)

View and export this data going back to 2024. Start your Free Trial

What is Psyence Biomedical Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Psyence Biomedical's interest expense for the six months ended in Mar. 2023 was $ 0.00 Mil. Psyence Biomedical does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in Mar. 2023.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Psyence Biomedical's Operating Income for the six months ended in Mar. 2023 was $ -3.13 Mil. Psyence Biomedical's Interest Expense for the six months ended in Mar. 2023 was $ 0.00 Mil. Psyence Biomedical has no long-term debt ⁽¹⁾. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Psyence Biomedical Interest Expense Historical Data

The historical data trend for Psyence Biomedical's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psyence Biomedical Interest Expense Chart

Psyence Biomedical Annual Data

Trend

Mar21

Mar22

Mar23

Interest Expense

Psyence Biomedical Semi-Annual Data
	Mar21	Mar22	Mar23
Interest Expense	-	-	-

Psyence Biomedical Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Psyence Biomedical (NAS:PBM) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Psyence Biomedical's Interest Expense for the six months ended in Mar. 2023 was $0.00 Mil. Its Operating Income for the six months ended in Mar. 2023 was $-3.13 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Mar. 2023 was $0.00 Mil.

Psyence Biomedical's Interest Coverage for the quarter that ended in Mar. 2023 is calculated as

Psyence Biomedical had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Psyence Biomedical Ltd has no debt.

Psyence Biomedical (Psyence Biomedical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Psyence Biomedical Ltd (NAS:PBM) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

121 Richmond Street West, Penthouse Suite 1300, Toronto, ON, CAN, M5H 2K1

Website

https://www.psyence.com

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Psyence Biomedical (Psyence Biomedical) Headlines

From GuruFocus

Thinking about buying stock in Psyence Biomedical, Micron Technology, Conservative Broadcast Media Journalism, Qualcomm, or Cibus?

By PRNewswire • 02-12-2024